Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C KinaseNicholas D. Adams, Dashyant Dhanak, Robert A. Copeland et al.|Journal of Medicinal Chemistry|2010Cited by 111
Abstract C63: Biological characterization of GSK2126458, a novel and potent inhibitor of phosphoinositide 3-kinase and the mammalian target of rapamycin (mTOR)Mary Ann Hardwicke, Kurt R. Auger, Hong Lu et al.|Molecular Cancer Therapeutics|2009Cited by 1